Difficulty: Medium
Average Score: 90%
Practice
Which one of the following drugs has caused hyperkalemia leading to cardiac arrest in patients with neurologic disorders?
Correct answer
C
Rationale
In this question, the correct answer is C) Succinylcholine. Succinylcholine is a depolarizing neuromuscular blocking agent that can cause hyperkalemia in patients with neurologic disorders such as spinal cord injury, stroke, or traumatic brain injury. This hyperkalemia can lead to cardiac arrest due to its effect on the potassium channels in skeletal muscle cells.
Option A) Baclofen is a muscle relaxant commonly used to treat spasticity in conditions like multiple sclerosis or spinal cord injury, but it does not typically cause hyperkalemia or cardiac arrest.
Option B) Dantrolene is a muscle relaxant that acts on the muscle directly and is used to treat conditions like malignant hyperthermia or spasticity, but it does not cause hyperkalemia leading to cardiac arrest.
Option D) Tubocurarine is a non-depolarizing neuromuscular blocking agent that does not typically cause hyperkalemia or cardiac arrest in patients with neurologic disorders.
In an educational context, understanding the physiological effects of different drugs on patients with neurological disorders is crucial for healthcare providers, especially those managing medications in critical care or anesthesia. Knowledge of potential adverse effects like hyperkalemia from succinylcholine is essential for safe and effective patient care. This question reinforces the importance of pharmacological knowledge and patient safety in clinical practice.
Option A) Baclofen is a muscle relaxant commonly used to treat spasticity in conditions like multiple sclerosis or spinal cord injury, but it does not typically cause hyperkalemia or cardiac arrest.
Option B) Dantrolene is a muscle relaxant that acts on the muscle directly and is used to treat conditions like malignant hyperthermia or spasticity, but it does not cause hyperkalemia leading to cardiac arrest.
Option D) Tubocurarine is a non-depolarizing neuromuscular blocking agent that does not typically cause hyperkalemia or cardiac arrest in patients with neurologic disorders.
In an educational context, understanding the physiological effects of different drugs on patients with neurological disorders is crucial for healthcare providers, especially those managing medications in critical care or anesthesia. Knowledge of potential adverse effects like hyperkalemia from succinylcholine is essential for safe and effective patient care. This question reinforces the importance of pharmacological knowledge and patient safety in clinical practice.